2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

Saturday, December 12, 2026
09:30 a.m. - 11:00 a.m.
MCCNO - 353-355
Technology and Procedures, Imaging, Omics Technologies, Bioinformatics, Treatment Considerations, Drug Development, Biological Therapies, Transplantation, Artificial Intelligence (AI), Machine Learning, Biological Processes, Pathogenesis, Immune Mechanism, Metabolism, Microbiome, Diseases, Immunology, GVHD, Research, Fundamental Science, Translational Research, Study Population, Human, Animal Model
PAPER

121 An interleukin 27 dependent lysosomal thiol reductase subverts regulatory T cell function and mitochondrial fitness by augmenting reductive stress during graft versus host disease

Jonathan Florentin, PhD, Mark Castleberry, PhD2, Alison Moe, PhD3, Alex Myers, BS4, Ravi Shah5, Wenwen Xu, PhD6, Jacek Zielonka, PhD7, Atrayee Ray, PhD8, Sridhar Rao, MD, PhD9, Anthony E Zamora, PhD10, William R Drobyski, MD11
1 Medical College of Wisconsin, Milwaukee, Wisconsin, United States
2 Medical College of Wisconsin, Milwaukee, Wisconsin, United States
3 Medical College of Wisconsin, Milwaukee, Wisconsin, United States
4 Medical College of Wisconsin, Milwaukee, Wisconsin, United States
5 Medical College of Wisconsin, Milwaukee, Wisconsin, United States
6 AbbVie Inc, Chicago, Illinois, United States
7 Medical College of Wisconsin, Milwaukee, Wisconsin, United States
8 Versiti Blood Research Institute, Milwaukee, Wisconsin, United States
9 Versiti Blood Research Institute, Milwaukee, Wisconsin, United States
10 University of California Davis, Davis, California, United States
11 Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Graft versus host disease (GVHD) pathophysiology is characterized by the failure to reconstitute the regulatory T cell (Treg) compartment to restore immune tolerance. The re-establishment of an effective regulatory network is constrained by the production of inflammatory cytokines that impair Treg survival and suppressive capability, although how this occurs is not well understood. To unveil therapeutically targetable inflammatory cytokine-driven pathways that adversely impact Treg reconstitution, we focused on the role of interleukin 27 (IL-27) which is produced by activated antigen presenting cells. To examine this question, we employed major and minor histocompatibility mismatched murine bone marrow transplantation models and observed that transplantation with IL-27R-/- marrow grafts or blockade of IL-27 signaling using an IL-27p28-specific antibody significantly improved survival and reduced pathological damage in GVHD target organs. Notably, both approaches also augmented the reconstitution of peripherally induced and thymically derived CD4+ Tregs in recipient animals. In addition, adoptive transfer of IL-27R-/- Tregs was more potent at suppressing GVHD lethality than wild type (WT) Tregs. To identify downstream IL-27-dependent pathways that regulated CD4+ Treg function, donor CD4+ Foxp3+ EGFP+ T cells were isolated from pooled livers and colons of mice transplanted with either WT or IL-27R-/- Foxp3+ EGFP+ marrow grafts and subjected to bulk RNA sequencing. Bioinformatic analysis identified the gene IFI30, which encodes the protein GILT, a gamma interferon inducible lysosomal thiol reductase, as one of the most highly upregulated genes in WT versus IL-27R-/- Tregs in both tissue sites. To confirm a direct linkage between IL-27 and GILT expression, in vitro-induced CD4+ Foxp3+ Tregs cultured with IL-27 were subjected to western blot analysis which demonstrated a linear correlation between IL-27 concentrations and GILT expression. In vivo studies also confirmed that GILT expression was increased in CD4+ Tregs isolated from the colon or livers of mice transplanted with WT versus IL-27R-/- marrow grafts. To determine if GILT expression was functionally significant, WT or GILT-/- CD4+ Foxp3+ EGFP+ Tregs were adoptively transferred into transplant recipients to prevent GVHD. These studies demonstrated increased Treg persistence in GVHD target organs and improved survival in mice reconstituted with GILT-/- CD4+ Tregs, confirming that these cells were more potent and that the functional inhibitory effects of IL-27/IL-27R signaling were mediated by downstream expression of GILT. Mechanistic studies revealed that WT CD4⁺ Tregs exhibited impaired glycolysis, oxidative phosphorylation, and fatty acid oxidation, together with increased mitochondrial reactive oxygen species compared with IL-27R⁻/⁻ Tregs, indicating profound GILT-mediated mitochondrial dysfunction. Since GILT is a thiol reductase, we hypothesized that Treg dysfunction was due to an increase in cellular reductants. Consistent with this hypothesis, we observed that WT CD4+ Tregs had significantly increased concentrations of free thiols, glutathione, NADH, and NADPH when compared to IL-27R-/- and GILT-/- CD4+ Tregs. Furthermore, pharmacological oxidation with menadione significantly improved mitochondrial oxidative phosphorylation in WT CD4+ Tregs directly supporting reductive stress as the primary cause of mitochondrial dysfunction. Western blot analysis revealed increased expression of NRF2, the master antioxidant transcription factor (TF), and decreased levels of KEAP1, which targets NRF2 for proteasomal degradation in WT Tregs, consistent with activation of a reductive stress program. Notably, WT Tregs had higher expression of TFEB, the master TF for lysosomal biogenesis, and pharmacological inhibition of TFEB with eltrombopag significantly reduced GILT expression. Conversely, co-incubation of WT Tregs with Torin1 which leads to TFEB dephosphorylation and nuclear translocation significantly increased GILT expression. Finally, CUT&Tag analysis demonstrated TFEB binding at the IFI30 promoter, establishing GILT as a direct TFEB transcriptional target. Collectively, these studies demonstrate that IL-27/IL-27R signaling activates a TFEB-dependent lysosomal transcriptional program that promotes GILT expression and identifies reductive stress as a previously unrecognized mechanistic pathway by which proinflammatory cytokines subvert CD4+ Treg function during GVHD.

Jonathan Florentin, PhD: No relevant conflicts of interest to declare.